Bay Street News, January 31st, 2024

MALVERN, Pa., Jan. 31, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused […]

BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming […]

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today […]

NEWARK, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies […]

Appointment effective February 12 following Nadim Yared’s retirement Hykes currently serves as Augmedics’ President and CEO, and has served on […]

WARRINGTON, Pa., Jan. 31, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company […]

SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, and […]

SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s […]

Hosts conference call on Thursday, February 15, 2024 NEW YORK and KUALA LUMPUR, Malaysia, Jan. 31, 2024 (GLOBE NEWSWIRE) — […]

TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) — VVC Exploration Corporation, dba VVC Resources, (“VVC”) or (the “Company”), (TSX-V:VVC and OTCQC:VVCVF) […]